Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Abbott
ABT
$180B
| $1B | 0.54% |
13,678,979
-29,193
| -0.2% | -$1.92M |
|
27
Eli Lilly
LLY
$1.07T
| $983M | 0.53% |
9,163,495
-845,273
| -8% | -$84.5M |
|
28
Intuitive Surgical
ISRG
$121B
| $974M | 0.52% |
5,091,537
-398,232
| -7% | -$70.7M |
|
29
UnitedHealth
UNH
$382B
| $967M | 0.52% |
3,635,040
+109,950
| +3% | +$28.6M |
|
|
ULTI
30
DELISTED
Ultimate Software Group Inc
ULTI
| $966M | 0.52% |
2,999,361
-226,458
| -7% | -$67M |
|
31
Microchip Technology
MCHP
$42.8B
| $957M | 0.51% |
24,251,898
-1,587,312
| -6% | -$70.1M |
|
|
CELG
32
DELISTED
Celgene Corp
CELG
| $936M | 0.5% |
10,461,658
+1,391,617
| +15% | +$123M |
|
|
33
CSX Corp
CSX
$98.6B
| $933M | 0.5% |
37,800,582
+9,536,418
| +34% | +$227M |
|
34
Intercontinental Exchange
ICE
$82.4B
| $914M | 0.49% |
12,202,306
+666,185
| +6% | +$50.1M |
|
35
Progressive
PGR
$124B
| $885M | 0.47% |
12,457,383
+361,810
| +3% | +$23.3M |
|
36
Neurocrine Biosciences
NBIX
$17.7B
| $881M | 0.47% |
7,162,465
-252,396
| -3% | -$28.6M |
|
37
Alphabet (Google) Class A
GOOGL
$3.91T
| $860M | 0.46% |
14,239,180
+551,000
| +4% | +$33.4M |
|
|
TMX
38
DELISTED
Terminix Global Holdings, Inc.
TMX
| $854M | 0.46% |
20,544,161
+154,596
| +0.8% | +$6.19M |
|
39
Steris
STE
$20.9B
| $851M | 0.45% |
7,437,198
-131,458
| -2% | -$14.9M |
|
40
Gartner
IT
$9.41B
| $846M | 0.45% |
5,339,576
+100,882
| +2% | +$14.6M |
|
|
AGN
41
DELISTED
Allergan plc
AGN
| $825M | 0.44% |
4,328,872
-449,827
| -9% | -$82.6M |
|
42
Lam Research
LRCX
$382B
| $817M | 0.44% |
53,880,300
-1,158,250
| -2% | -$19.8M |
|
43
Broadridge
BR
$17.2B
| $817M | 0.44% |
6,193,580
+77,517
| +1% | +$9.84M |
|
44
Bank of America
BAC
$435B
| $811M | 0.43% |
27,529,779
-126,188
| -0.5% | -$3.84M |
|
45
Home Depot
HD
$332B
| $797M | 0.43% |
3,846,265
+75,918
| +2% | +$15.3M |
|
46
WEX
WEX
$6.11B
| $773M | 0.41% |
3,847,890
-119,436
| -3% | -$22.9M |
|
47
Estee Lauder
EL
$29B
| $747M | 0.4% |
5,143,117
+701,827
| +16% | +$97.4M |
|
48
Coca-Cola
KO
$354B
| $734M | 0.39% |
15,897,330
-25,790
| -0.2% | -$1.18M |
|
49
Crown Castle
CCI
$32.7B
| $734M | 0.39% |
6,595,096
-12,045
| -0.2% | -$1.34M |
|
50
Cooper Companies
COO
$13.7B
| $726M | 0.39% |
10,472,256
-2,504
| -0% | -$161K |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.